"Empresa de servicios de Investigación Clínica, reclutamiento y seguimiento de pacientes."

During the past decade, Clinical Research Institute S.C. conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Institute S.C." #1 sponsor was "R-Pharm International, LLC" with 2 trials, followed by "Biota Scientific Management Pty Ltd" with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored, "Fresenius Kabi SwissBioSim GmbH" with 1 trials sponsored and "Sandoz" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Institute S.C." #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator and "Hexal AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Institute S.C." are "Rheumatoid Arthritis" (3 trials), "Influenza" (1 trials), "Moderate to Severe Plaque Psoriasis" (1 trials), "Plaque Type Psoriasis" (1 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "Clinical Research Institute S.C." in a lesser frequency.

Most popular intervention types in "Clinical Research Institute S.C." are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "40 mg Laninamivir Octanoate" (1 trials), "80 mg Laninamivir Octanoate" (1 trials), "Adalimumab - GP2017" (1 trials) and "Adalimumab - US licensed Humira" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Institute S.C." are 6 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Research Institute S.C.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Clinical Research Institute S.C., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Institute S.C., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".